Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | THRB | P10828 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2349410 | 0.91 | TSHR (0.39) | TSHRLMNATHRB | |
| SCHEMBL28420462 | 0.89 | — | — | |
| SCHEMBL2931479 | 0.88 | TSHR (0.44) | TSHRLMNATHRB | |
| SCHEMBL700161 | 0.88 | TSHR (0.44) | TSHRLMNATHRB | |
| Hydrochloric Acid SCHEMBL17287830 | 0.86 | TSHR (0.35) | TSHRLMNATHRB | |
| Hydrochloric Acid SCHEMBL705678 | 0.86 | TSHR (0.42) | TSHRLMNATHRB | |
| Acetic Acid SCHEMBL31296129 | 0.85 | AKR1B1 (0.36) | TSHR | |
| SCHEMBL21834966 | 0.85 | ANPEP (0.33) | — | |
| SCHEMBL300005 | 0.83 | — | — | |
| SCHEMBL294768 | 0.83 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 150 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4568984-A1 | PROCESS FOR MANUFACTURING AN ANTIBIOTIC MACROCYCLIC PEPTIDE | F. Hoffmann-La Roche AG (CH) | 2025-06-18 | — | — | EP | claimed |
| CN-119677765-A | Method for producing antibiotic macrocyclic peptides | 豪夫迈·罗氏有限公司 | 2025-03-21 | — | — | CN | claimed |
| WO-2024033278-A1 | PROCESS FOR MANUFACTURING AN ANTIBIOTIC MACROCYCLIC PEPTIDE | F. HOFFMANN-LA ROCHE AG (CH) | 2024-02-15 | — | — | WO | claimed |
| EP-4267591-A2 | ORGANOMETALLIC COMPOUNDS | Umicore AG & Co. KG (DE) | 2023-11-01 | — | — | EP | claimed |
| CN-116802187-A | Organometallic compounds | 优米科尔股份公司及两合公司 | 2023-09-22 | — | — | CN | claimed |
| CN-116003927-B | Butyl rubber capable of being repeatedly processed and preparation method thereof | 山东泰瑞丰新材料有限公司 | 2023-08-01 | — | — | CN | claimed |
| CN-114479047-B | Method for preparing quaternary phosphonium salt-containing polymer from epoxy monomer, product and application thereof | 浙江大学 | 2023-07-18 | — | — | CN | claimed |
| WO-2022136049-A2 | ORGANOMETALLIC COMPOUNDS | UMICORE AG & CO. KG (DE) | 2022-06-30 | — | — | WO | claimed |
| CN-114479047-A | Method for preparing polymer containing quaternary phosphonium salt from epoxy monomer, product and application thereof | 浙江大学 | 2022-05-13 | — | — | CN | claimed |
| CN-111518145-A | Cyanide-bridged metal organic compound with intramolecular magnetic transformation, and preparation method and application thereof | 荆楚理工学院 | 2020-08-11 | — | — | CN | claimed |
| CN-111356685-A | Process for producing 2-substituted-3-ethylsulfonylpyridine compound | 住友化学株式会社 | 2020-06-30 | — | — | CN | claimed |
| EP-0004409-B1 | A PROCESS FOR PREPARING 1,7-OCTADIENE | SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) | 1982-04-21 | — | — | EP | claimed |
| EP-0008139-B1 | A PROCESS FOR PREPARING 1,7-OCTADIENE | SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) | 1982-02-24 | — | — | EP | claimed |
| US-12492180-B2 | Process and intermediates for the preparation of Voxelotor | CURIA SPAIN, S.A.U. (ES) | 2025-12-09 | — | — | US | disclosed |
| EP-4590785-A1 | QUANTUM DOT SHELL SYNTHESIS | QustomDot B.V. (BE) | 2025-07-30 | — | — | EP | disclosed |
| EP-4568984-A1 | PROCESS FOR MANUFACTURING AN ANTIBIOTIC MACROCYCLIC PEPTIDE | F. Hoffmann-La Roche AG (CH) | 2025-06-18 | — | — | EP | disclosed |
| CN-1429228-A | Bidentate ligands useful in catalyst system | SHELL INT RESEARCH (NL) | 2003-07-09 | — | — | CN | disclosed |
| CN-1422248-A | Process for the carbonylation of pentenenitrile | SHELL INT RESEARCH (NL) | 2003-06-04 | — | — | CN | disclosed |
| CN-1400202-A | Prepn of dialkyl ketone | BASF AG (DE) | 2003-03-05 | — | — | CN | disclosed |
| US-4595701-A | Reacting carbon monoxide and hydrogen in liquid phase in the presence of a rhodium and trialkylphosphine catalyst | AGENCY OF INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) | 1986-06-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12492180-B2 | Process and intermediates for the preparation of Voxelotor | VPS51, KIF15, VAT1 | TSHR 4675/4885LMNA 2043/4885THRB 4716/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.